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Letters to the Editorindicated, the intimal injury caused by
the tip of the guiding catheter carries
a high likelihood of being directed ret-
rograde, and thus the flap can poten-
tially close and seal under antegrade
aortic flow pressure. Although the dis-
sectionmayprogress antegrade, a report
of iatrogenic AD after cardiac cathe-
terization found that most of the dissec-
tions were limited to the right coronary
sinus, and there was a favorable out-
come with conservative treatment.5 In
support of their management decision,
Timek and colleagues1 cited an obser-
vational series of 10 medically treated
patients with AD diagnosed after an in-
terval as long as 12 years (mean 52.6
months) after initial cardiac surgery
(half of them for aortic pathologies).2
Thesepatients simply represent a surviv-
ing selection of an unknown number of
affected cases. In the absence of a de-
nominator, this is insufficient evidence
to define retrospectively a ‘‘paradigm
change’’ in the management of an acute
(potentially life-threatening) vascular
complication. Late survivors of AD
with aortic wall pathology and open
false lumen must be distinguished from
those with catheter-induced local aortic
injury. Those patients with previous CS
whoare in hemodynamically stable con-
dition may expect an excellent outcome
with nonoperative management.1,5
The decision for surgical or nonsur-
gical therapy remains challenging in
patients with other causes of dissec-
tion. The 10-year survivalwith surgical
treatment was reported as 68%, which
was not significantly different from
that for spontaneous AD.4 In the ab-
sence of sufficient data to estimate the
prognosis of medically treated AD in
patients with previous CS, the decision
will remain difficult, particularly in the
case of relatively young patients.
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j.jtcvs.2012.09.088Reply to the Editor:
I appreciate the thought-provoking
arguments that our case report has gen-
erated.StangerandPepperpresentabal-
anced discussion of the controversial
subject of surgical intervention in pa-
tients with acute type A aortic dissec-
tion (TAAD) with previous cardiac
surgery. I agree that patients with previ-
ous cardiac surgery and spontaneous
TAAD should be treated surgically in
the absence of prohibitive comorbid-
ities. These patients do have signifi-
cantly higher operative mortality,
however, as illustrated by a study pub-
lished since the acceptance of our case
report.Klodell andcolleagues1 reported
a disparity in hospital morality of 9.7%
versus 38.7% between primary sternot-
omy and resternotomy among patients
treated for acute TAAD in a propensity
score–matched analysis. Interestingly,
patients with previous surgery had
a significantly higher incidence of aor-
tic rupture, contained in most cases,
suggesting that adhesions from previ-
ous surgical procedure may not provide
‘‘buttressing’’ after all against this cata-
strophic complication. Medical therapyof Thoracic and Cardiovascular Surgefor TAAD has been associated with
58%mortality in a large registry expe-
rience,2 and as such outcomes of surgi-
cal therapy in resternotomy TAAD
appear favorable, although patients
chosen for medical therapy usually
have a prohibitive risk profile. The pa-
tientdescribed inour reportwasayoung
woman with stable hemodynamics and
a catheter-induced TAAD. We agree
that this represents an important distinc-
tion, because the mechanism of aortic
injury in this settingmay bemore prone
to healing than a spontaneous TAAD
and the underlying aortic pathology
may be less significant; however, clini-
cal vigilance, close observation, serial
imaging and echocardiographic assess-
ment, and a low threshold for operative
intervention remain paramount. Be-
cause scant data from the literature are
available to guide the treatment of
TAAD in patients with previous cardiac
surgery, clinical judgment and local ex-
periencewillmost likely continue to de-
termine the mode of therapy.
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PRECONDITIONING IN
CHILDREN WITH CYANOTIC
HEART DISEASE: LOST IN
TRANSLATION?
To the Editor:
I read with great interest a recent re-
port of Pavione and colleagues1 thatry c Volume 145, Number 2 613
Letters to the Editorassessed the late remote ischemic pre-
conditioning (RIPC) in 22 children
who underwent cardiac surgery with
cardiopulmonary bypass. The authors
concluded that ‘‘late remote ischemic
preconditioning did not provide clini-
cally relevant cardioprotection to chil-
dren undergoing cardiopulmonary
bypass.’’ A few comments seem to be
appropriate. It appears that at least 5
children in their RIPC group had cya-
notic heart disease (Taussig-Bing
anomaly, tricuspid atresia, and tetral-
ogyofFallot). Inasmuch as the2groups
in this study appear comparable, the
children with cyanotic heart disease
have chronic hypoxia before surgery.
Is it possible to further precondition
the patients with chronic hypoxia by
brief intermittent episodes of limb is-
chemia induced before surgery? This
question remains to be answered.
My colleagues and I2 have previ-
ously demonstrated in a randomized
controlled trial a clinically relevant
beneficial effect of theRIPC in children
who underwent preconditioning imme-
diately before surgery. Pavione and col-
leagues used the sameRIPC stimulus to
assess a late phase of protection. We3,4
have previously demonstrated that the
RIPC modifies gene expression both
early and late in human blood and in
the myocardium of the experimental
animals. Furthermore, it appears that
intraoperative ischemia–reperfusion
itself induces an early myocardial
gene expression in the children
undergoing heart surgery.5 Thus, both
intermittent preoperative (ie, RIPC)
and prolonged intraoperative ische-
mia–reperfusion induce changes at the
genomic level. One would expect that
chronic hypoxia of the cyanotic heart
disease does the same. Do these geno-
mic changes translate into proteomic
response? This is yet unknown. Our re-
cent, yet unpublished, randomized con-
trolled trial performed in 40 children
undergoing surgery for tetralogy ofFal-
lot indicated that the myocardial phos-
phorylated protein signaling is already
activated in children with chronic hyp-
oxia. Thus, regardless of whether the614 The Journal of Thoracic and CRIPC-induced activation of gene ex-
pression translates into proteomic re-
sponse or not, its clinical effect may
be lost in children with cyanotic heart
disease.
I commend Pavione and col-
leagues on their interesting study
and look forward to seeing whether
the RIPC will find a clinical applica-
tion in children undergoing heart
surgery. Time will show. At the
meantime, the researchers should be
cautioned against including patients
with chronic hypoxia into the trials
inasmuch as chronic hypoxia may
mask the effects of the ischemic
preconditioning.
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We thank Dr Konstantinov1 for his
interesting comments on our article.2ardiovascular Surgery c February 2013We do not, however, believe that the
presence of patients with cyanotic
heart disease in the group undergoing
remote ischemic preconditioning
(RIPC) in our study may have masked
the effects of the ischemic stimulus,
because there were actually 9 patients
with cyanotic heart defects in the
RIPC group (75%) and 6 in the con-
trol group (60%; P ¼ .65). In addi-
tion, preoperative oxygen saturations
were similar in the RIPC and control
groups (mean  SD, 89%  11% vs
89%  7%, respectively; P ¼ .84).
We emphasize that studies performed
in adults undergoing coronary artery
bypass surgery3 and in infants with
ventricular septal defect,4 in which
cases chronic hypoxia would not be
a confounding factor, also failed to
demonstrate any clinically significant
effect of RIPC. Moreover, the useful-
ness of RIPCwould bemost important
in patients at high risk of postopera-
tive complications, such as those in-
cluded in our study. Nevertheless,
many infants with complex congenital
heart disease have some degree of pre-
operative cyanosis. Considering that
RIPC is an innocuous, inexpensive,
and simple procedure, we hoped that
it would decrease inflammation and
postoperative morbidity. Unfortu-
nately, we did not observe these ef-
fects. It thus seems evident that
RIPC with brief periods of limb occlu-
sion, as currently performed, lacks
clinical applicability in patients un-
dergoing heart surgery with cardio-
pulmonary bypass.
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